China CAS:107724-20-9 Manufacturer

We've been experienced manufacturer. Wining the majority on the crucial certifications of its market for CAS:107724-20-9, Top quality and competitive rates make our products and solutions appreciate a higher name all around the word.
CAS:107724-20-9, Our products are very popular in the word, like South American, Africa, Asia and so on. Companies to "create first-class products" as the goal, and strive to provide customers with high quality products, provide high-quality after-sales service and technical support, and customer mutual benefit, create a better career and future!

Hot Products

  • Fluticasone Furoate

    Fluticasone Furoate

    Fluticasone furoate has In-house specifications. DMF under filing.

    CAS:397864-44-7

  • Mirabegron

    Mirabegron

    Mirabegron has In-house specification. DMF approved..

    CAS:223673-61-8

  • 16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone

    16alpha-Hydroxyprednisolone has DMF available.

    CAS:13951-70-7

  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

  • 4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid

    4-aza-5α-androstan-1-ene-3-oxo-17β-carboxylic acid is an intermediate of Dutasteride.

    CAS:103335-55-3

  • N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide

    N-tert-butyl-3-oxo-4-aza-5α-androst-17β-carboxamide is an intermediate of Dutasteride.

    CAS:98319-24-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept